A brief History of MariPharm
Founded in 1995, MariPharm is one of the world’s leading manufacturers and distributors of CBD oil. Backed up by over twenty-four years of experience in the field of medicinal cannabis research, we take great pride in our contributions to the standardisation of high-quality products.
Our journey, spanning over the course of two-and-a-half decades, has transformed MariPharm from a small, yet ambitious research group into a leading researcher, manufacturer and supplier of medicinal cannabis. Throughout the years, we’ve had the pleasure of collaborating with a large number of prominent scientists, universities, pharmacies and innovative companies, all of which have been a tremendous help to our cause. It is precisely thanks to their efforts, combined with the unwavering dedication of our teams that we’ve managed to achieve what we have today.
During our years in the field, we’ve always strived towards perfection. Our experts are continually labouring to further develop and improve our innovative extraction techniques, ensuring a more efficient and effective outcome. And, we’re happy to say that our efforts have not gone unnoticed.
Our journey so far
Our journey began in 1995 when our team was granted permission to grow cannabis for medicinal purposes. This year also marked the time when we became the supplier of Netherland’s first medicinal cannabis Pharmacy with Medicinal Grade Cannabis® (MGC®), a privilege that we’ve enjoyed almost exclusively in the following eight years, by providing high-quality products for about 85% of all Dutch pharmacies.
In 1996, our team’s efforts to further the research into medicinal cannabis gained recognition from the Scientific Institute of Dutch Pharmacists. Subsequently, MariPharm BV also earned a spot in a number of scientific organisations:
- NVF – the Dutch Phyto-therapy Union
- NVGO - the Dutch Union for Herbal Medicine Research
- German NCM – the Association for Cannabinoid Medicines
- ICRS – the International Cannabis Research Society
1999 marked MariPharm’s next big push for the furthering of medicinal cannabinoid research, with members of our team receiving an invitation from the Pharmaceutical experts in the UK.
In 2002, MariPharm was given the go-ahead from the Dutch Ministry of Health to break The Single Convention of New-York (1961), by exporting 1 kilogram of Medicinal Grade Cannabis® (MGC®) to the shores of the United Kingdom.
Throughout 2003, our experts had the pleasure of working closely with several departments of the Netherlands Organisation for Applied Scientific Research, leading to the discovery of THC-a, which has been patented ever since.
In 2005, MariPharm presented its first genetics under the European Plant Breeders' Right.
In 2007, the Dutch Ministry of Health placed an order for MGC for distribution through the Dutch pharmacies.
2008 was a year of spectacular progress for our teams, as we were chosen for the role of advisor by a number of prestigious Medicinal Cannabis Organisation in Israel, Canada, Uruguay, America and the Czech Republic.
In recognition of our efforts in advising and consulting M. de Wit, a Canadian Medicinal Cannabis company in 2013, we were privileged to receive a special benefit working license as a medical cannabis consultant from the Canadian Authorities.
In 2017, our company was appointed as supervisor of Cannabis Farms by the Dutch Government’s Security Council.
And finally, 2018 marked the official launch of MariPharm’s United Kingdom branch, bringing the world’s highest quality CBD oils to the UK.
During our years of dedication, we’ve earned the backing of the Dutch Ministry of Health, Sports and Welfare, along with the support of multiple world-renowned organisations. Today, it is our products that set the worldwide standard for production and analysis of cannabidiol.
None of this would’ve been possible, if not for the dedication and utmost professionalism of our experts. We’ve managed to develop, adopt and continually build upon our very own revolutionary extraction process, and have now found ourselves setting the industry standard of quality for CBD oil as a nutritional food supplement.
We maintain a state-of-the-art research and a development laboratory, complete with third-party quality oversight and dedicated testing facilities. Our teams span over a hundred highly trained and experienced professionals, dedicated to our cause. Each and every batch of CBD oil that leaves our premises is tested by a highly renowned laboratory, appointed and approved by the Dutch Government for the issuing of Certificates of Analysis. The MariPharm CBD oils are designed to meet the stringent EU GMP standards.